KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Interest Expenses (2016 - 2025)

Pacific Biosciences Of California has reported Interest Expenses over the past 14 years, most recently at $1.7 million for Q4 2025.

  • Quarterly results put Interest Expenses at $1.7 million for Q4 2025, down 36.89% from a year ago — trailing twelve months through Dec 2025 was $7.0 million (down 48.15% YoY), and the annual figure for FY2025 was $7.0 million, down 48.15%.
  • Interest Expenses for Q4 2025 was $1.7 million at Pacific Biosciences Of California, roughly flat from $1.7 million in the prior quarter.
  • Over the last five years, Interest Expenses for PACB hit a ceiling of $3.7 million in Q1 2022 and a floor of $1.7 million in Q1 2025.
  • Median Interest Expenses over the past 5 years was $3.6 million (2023), compared with a mean of $3.1 million.
  • Biggest five-year swings in Interest Expenses: soared 570.04% in 2021 and later tumbled 51.41% in 2025.
  • Pacific Biosciences Of California's Interest Expenses stood at $3.5 million in 2021, then increased by 4.86% to $3.6 million in 2022, then decreased by 2.11% to $3.6 million in 2023, then decreased by 22.79% to $2.8 million in 2024, then crashed by 36.89% to $1.7 million in 2025.
  • The last three reported values for Interest Expenses were $1.7 million (Q4 2025), $1.7 million (Q3 2025), and $1.7 million (Q2 2025) per Business Quant data.